MA2-014

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameMA2-014
Drug Alias NameBET and oncogenic kinase inhibitors (Aptose)
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase JAK2 inhibitorsBromodomain-containing protein 4 inhibitorsAnticancer protein kinase inhibitors
TargetsTyrosine-protein kinase JAK2Bromodomain-containing protein 4
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesH Lee Moffitt Cancer Center & Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAptose Biosciences Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A